Feb 05, 2026
175:174
For every 174 shares held, investors received 175. The price per share adjusted from $0.71 to $0.71.
The split itself did not change the total investment value.
OncoSil Medical Ltd (ASX:OSL) operates in the Medical specialties industry.
OncoSil Medical Ltd company overviewOncoSil Medical Ltd's most recent stock split was on February 5, 2026. It was a 175-for-174 forward split, so shareholders received 175 shares for every 174 they held.
OncoSil Medical Ltd (ASX:OSL) has split its stock 7 times: a 108-for-97 split on September 3, 2010, a 564-for-553 split on May 6, 2020, a 165-for-163 split on May 5, 2022, a 16-for-13 split on March 22, 2023, a 18-for-17 split on March 27, 2024, a 1-for-400 reverse split on June 13, 2025, and a 175-for-174 split on February 5, 2026.
OncoSil Medical Ltd has split its stock 7 times. This history records 7 splits between September 3, 2010 and February 5, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In OncoSil Medical Ltd's 175-for-174 split on February 5, 2026, every 174 shares became 175 shares.
OncoSil Medical Ltd has not announced a new split in our records. Its most recent split was on February 5, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:OSL split will appear on this page.
Already premium?